Rescriptor Interactions
There are 482 drugs known to interact with Rescriptor (delavirdine), along with 2 disease interactions. Of the total drug interactions, 207 are major, 226 are moderate, and 49 are minor.
- View all 482 medications that may interact with Rescriptor
- View Rescriptor disease interactions (2)
Most frequently checked interactions
View interaction reports for Rescriptor (delavirdine) and the medicines listed below.
- Acidophilus (lactobacillus acidophilus)
- Adcetris (brentuximab)
- Adriamycin RDF (doxorubicin)
- Advate (antihemophilic factor)
- Afinitor (everolimus)
- Alimta (pemetrexed)
- Aptivus (tipranavir)
- Avastin (bevacizumab)
- Baraclude (entecavir)
- Besponsa (inotuzumab ozogamicin)
- bleomycin
- Blincyto (blinatumomab)
- Corlanor (ivabradine)
- Crixivan (indinavir)
- Enbrel (etanercept)
- Isentress (raltegravir)
- Kalydeco (ivacaftor)
- Matulane (procarbazine)
- Norvir (ritonavir)
- Oncovin (vincristine)
- Orfadin (nitisinone)
- Prezista (darunavir)
- Ravicti (glycerol phenylbutyrate)
- Repatha (evolocumab)
- Simulect (basiliximab)
- Stivarga (regorafenib)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir)
- Tecentriq (atezolizumab)
- Trizivir (abacavir / lamivudine / zidovudine)
- Vimizim (elosulfase alfa)
Rescriptor disease interactions
There are 2 disease interactions with Rescriptor (delavirdine) which include:
Report options
QR code containing a link to this page
More about Rescriptor (delavirdine)
- Rescriptor consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: NNRTIs
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
